← Back to Search

Device

High-frequency repetitive transcranial magnetic stimulation for Spinal Cord Injury (rTMS Trial)

N/A

Recruiting

Research Sponsored by Kessler Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

rTMS Trial Summary

This trial is testing a new treatment for spinal cord injury using magnetic stimulation. The goal is to see if it is safe and effective.

rTMS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

GRASSP

Neuro Recovery Scale (NRS).

rTMS Trial Design

1Treatment groups

Experimental Treatment

Group I: SCI GroupExperimental Treatment1 Intervention

Complete testing at Baseline, Post, and 6 month follow up. Intervention includes 15 treatment sessions (3-5 times per week) with HF-rTMS & 6 month follow-up. Following HF-rTMS, there will be 30 minutes of arm and hand training. Each session will last for approximately 60 mins. At baseline, post and 6 months, the following evaluations to evaluate safety and other related measures. These measures include a safety and pain questionnaire, spasticity measurement, a physician or clinician evaluation to determine motor and sensory neurological level of injury, hand and arm function measurement, evaluation of ability to perform everyday tasks, and measures to determine level of brain function.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

High-frequency repetitive transcranial magnetic stimulation

2015

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor

173 Previous Clinical Trials

10,688 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to volunteer for this clinical investigation?

"At this time, the clinical trial is open to those aged 18-55 who have been diagnosed with an incomplete spinal cord injury between C2 and C6 levels of the spine. Outpatients must have experienced their damage for at least 6 months; inpatient injuries cannot be more than 8 weeks old. In addition, patients' diagnoses must fulfill grade A, B, C or D criteria set by the American Spinal Injury Association's Impairment Scale."

Answered by AI

What is the aggregate participation in this medical experiment?

"Yes, the data on clinicaltrials.gov confirms that this research project is currently recruiting participants. It was first released on August 20th 2022 and most recently updated October 12th of the same year. The trial seeks to enrol a total of 20 patients from one medical centre."

Answered by AI

Are there any opportunities for enrollment in this experiment?

"Clinicaltrials.gov confirms that this clinical trial, which was initiated on August 20th 2022 is actively looking for participants. The research study's details were last modified on October 12th 2022."

Answered by AI

Are participants of this experiment restricted to individuals aged 20 or younger?

"The age range criteria for this medical study necessitates that participants are between 18 to 55 years old. In contrast, there exists 37 trials specifically designed for the under-eighteens and 307 studies centered around those aged 65+."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Repetitive Transcranial Magnetic Stimulation to Promote Regeneration in Persons With SCI

2022. "Repetitive Transcranial Magnetic Stimulation to Promote Regeneration in Persons With SCI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05333770.

All > Transcranial Magnetic Stimulation